Hara Akihito, Yashima Kazuo, Yasugi Akiko, Koda Masaharu, Kawaguchi Koichiro, Harada Kenichi, Andachi Hironobu, Shiota Goshi, Ito Hisao, Murawaki Yoshikazu
Division of Medicine and Clinical Science, Faculty of Medicine, Tottori University, Yonago 683-8504, Japan.
Oncol Rep. 2007 Sep;18(3):553-9.
An increasing number of tumor suppressor genes (TSGs) that are inactivated by hypermethylation of CpG islands in the promoter have been reported in gastric carcinomas. The aim of this study is to evaluate the clinical significance of TSG protein expression, which correlates with the promoter status, methylated or not, during the early stages of gastric carcinogenesis and to examine its relationship with mucin phenotype. The protein expression of 4 TSGs including Fhit, Mlh1, p16INK4A and E-cadherin was examined using immunohistochemical methods in 103 early gastric neoplasias, comprising 41 adenomas and 62 intramucosal carcinomas, obtained by endoscopic mucosal resection. In addition, phenotypic expression patterns (gastric-, intestinal- and mixed-phenotypes) were also examined. The expression of Fhit, Mlh1, p16 and E-cadherin was lost or reduced in 7.3, 12.2, 12.2 and 9.8% of the adenomas and in 35.5, 29.0, 29.0 and 32.3% of the intramucosal carcinomas, respectively. The absent expression of p16 was significantly associated with the degree of dysplasia in the adenomas (p=0.038). The average number of proteins among the 4 TSGs, whose expression was lost or reduced per sample, was significantly higher in the intramucosal carcinomas (1.35) than in the adenomas (0.41) (p=0.00013). Similarly, the average number was significantly higher in the gastric-type tumors (2.05) than in the intestinal-type tumors (0.49) (p=0.0000019). We demonstrated an increase in the number of TSG proteins whose expression is reduced or lost in the early stages of gastric tumorigenesis, and that this increase is associated with histological grade and gastric phenotype.
已有报道称,在胃癌中,越来越多的肿瘤抑制基因(TSGs)因启动子区域CpG岛的高甲基化而失活。本研究旨在评估肿瘤抑制基因蛋白表达在胃癌发生早期阶段的临床意义,该表达与启动子状态(甲基化与否)相关,并探讨其与黏蛋白表型的关系。采用免疫组化方法检测了103例早期胃肿瘤(包括41例腺瘤和62例黏膜内癌)中4种肿瘤抑制基因(Fhit、Mlh1、p16INK4A和E-钙黏蛋白)的蛋白表达,这些样本均通过内镜黏膜切除术获取。此外,还检测了表型表达模式(胃型、肠型和混合型)。Fhit、Mlh1、p16和E-钙黏蛋白的表达在腺瘤中分别有7.3%、12.2%、12.2%和9.8%缺失或降低,在黏膜内癌中分别有35.5%、29.0%、29.0%和32.3%缺失或降低。p16的缺失表达与腺瘤的发育异常程度显著相关(p=0.038)。每个样本中表达缺失或降低的4种肿瘤抑制基因的平均数量,在黏膜内癌(1.35)中显著高于腺瘤(0.41)(p=0.00013)。同样,胃型肿瘤(2.05)中的平均数量显著高于肠型肿瘤(0.49)(p=0.0000019)。我们证明了在胃肿瘤发生早期阶段,表达降低或缺失的肿瘤抑制基因蛋白数量增加,且这种增加与组织学分级和胃表型相关。